Affluent Medical SA (EPA:AFME)

Market Cap	55.09M
Revenue (ttm)	5.35M
Net Income (ttm)	-14.74M
Shares Out	39.35M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	958
Average Volume	10,353
Open	1.420
Previous Close	1.400
Day's Range	1.400 - 1.420
52-Week Range	1.160 - 2.000
Beta	0.62
RSI	59.38
Earnings Date	Sep 26, 2025

About Affluent Medical

Affluent Medical SA, a medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France. The company offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. Affluent Medical SA was founded in 2011 and is headquartered in Aix-en-Provence, France...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2011
• Employees: 63
• Stock Exchange: Euronext Paris
• Ticker Symbol: AFME

Financial Performance

In 2024, Affluent Medical's revenue was 5.35 million, an increase of 337.09% compared to the previous year's 1.22 million. Losses were -14.74 million, -5.84% less than in 2023.